Literature DB >> 2866074

Plasma peptide YY (PYY) in dumping syndrome.

T E Adrian, R G Long, H S Fuessl, S R Bloom.   

Abstract

The newly isolated hormonal peptide PYY is mainly localized to endocrine cells of the lower intestinal mucosa. The release of PYY by oral glucose was studied in six patients with the dumping syndrome to ascertain the effect of this condition on PYY release. Plasma PYY concentrations were greatly increased following oral glucose in patients with the dumping syndrome compared with healthy controls. In a separate series of experiments, the effect of somatostatin infusion on the PYY release by glucose in these patients was investigated. The release of PYY was completely blocked by infusion of somatostatin, and its release from the bowel in normal subjects may therefore be modulated by local somatostatin in the gut. PYY has been shown to inhibit gastric acid secretion and emptying, at plasma concentrations similar to those seen after glucose, in patients with the dumping syndrome. PYY may therefore be a factor involved in the pathophysiological changes associated with this condition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866074     DOI: 10.1007/bf01314048

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Enteroglucagon release in the dumping syndrome.

Authors:  S R Bloom; C M Royston; J P Thomson
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

2.  Vascular effects of the peptides PYY and PHI: comparison with APP and VIP.

Authors:  J M Lundberg; K Tatemoto
Journal:  Eur J Pharmacol       Date:  1982-09-10       Impact factor: 4.432

3.  Somatostatin and the gut.

Authors:  S R Bloom
Journal:  Gastroenterology       Date:  1978-07       Impact factor: 22.682

4.  Elevation of plasma neurotensin in the dumping syndrome.

Authors:  A M Blackburn; N D Christofides; M A Ghatei; D L Sarson; F H Ebeid; D N Ralphs; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1980-10       Impact factor: 6.124

5.  Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility.

Authors:  J M Lundberg; K Tatemoto; L Terenius; P M Hellström; V Mutt; T Hökfelt; B Hamberger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

6.  The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man.

Authors:  T E Adrian; A J Barnes; R G Long; D J O'Shaughnessy; M R Brown; J Rivier; W Vale; A M Blackburn; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

7.  Effects of peptide YY and neuropeptide Y on gastric emptying in man.

Authors:  J M Allen; M L Fitzpatrick; J C Yeats; K Darcy; T E Adrian; S R Bloom
Journal:  Digestion       Date:  1984       Impact factor: 3.216

8.  Inhibition of interdigestive contractile activity in the stomach by peptide YY in Heidenhain pouch dogs.

Authors:  T Suzuki; M Nakaya; Z Itoh; K Tatemoto; V Mutt
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

9.  Human distribution and release of a putative new gut hormone, peptide YY.

Authors:  T E Adrian; G L Ferri; A J Bacarese-Hamilton; H S Fuessl; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

10.  Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides.

Authors:  K Tatemoto; V Mutt
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

View more
  14 in total

1.  Basal and fat-stimulated plasma peptide YY levels in celiac disease.

Authors:  P J Wahab; W P Hopman; J B Jansen
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Peptide YY concentrations in normal ileum and colon and in idiopathic inflammatory bowel disease.

Authors:  T R Koch; D R Roddy; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

Review 3.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Gastric emptying and postprandial PYY response after biliopancreatic diversion with duodenal switch.

Authors:  Jakob Hedberg; Hans Hedenström; F Anders Karlsson; Britt Edén-Engström; Magnus Sundbom
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

5.  Sympathoadrenal activation and the dumping syndrome after gastric surgery.

Authors:  D J Mehagnoul-Schipper; J W Lenders; J J Willemsen; W P Hopman
Journal:  Clin Auton Res       Date:  2000-10       Impact factor: 4.435

6.  Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor.

Authors:  H S Füessl; T E Adrian; L O Uttenthal; S R Bloom
Journal:  Klin Wochenschr       Date:  1988-10-03

7.  Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying.

Authors:  J M Nightingale; M A Kamm; J R van der Sijp; M A Ghatei; S R Bloom; J E Lennard-Jones
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

8.  Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon.

Authors:  T E Adrian; G H Ballantyne; W E Longo; A J Bilchik; S Graham; M D Basson; R P Tierney; I M Modlin
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

9.  Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice.

Authors:  Xu-Feng Huang; Yinghua Yu; Yulin Li; South Tim; Chao Deng; Qing Wang
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

10.  Long-term effects of lipase inhibition by orlistat on gastric emptying and orocecal transit time of a solid meal.

Authors:  Piotr Kocełak; Barbara Zahorska-Markiewicz; Krzysztof Jonderko; Magdalena Olszanecka-Glinianowicz; Agnieszka Zak-Gołab; Michał Holecki; Magdalena Kamińska; Małgorzata Szymszal
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.